< Back to all Breaking News
SIOX
12/2/2020 07:12am
Sio Gene Therapies reports first patient dosed in AXO-AAV-GM1 trial 
Don't miss out!
We read the Wall Street research, SEC filings and press releases so you don't have to.
Sign up for our 14-day free trial to read this story.
